Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbbVie

187.11
+2.261.22%
Post-market: 186.04-1.0750-0.57%19:59 EDT
Volume:4.43M
Turnover:828.41M
Market Cap:330.51B
PE:79.96
High:188.20
Open:184.94
Low:184.90
Close:184.85
Loading ...

Innoviva Inc. Announces FDA Acceptance of New Drug Application for Zoliflodacin, Paving Way for New Gonorrhea Treatment

Reuters
·
10 Jun

Bernstein Sticks to Their Hold Rating for AbbVie (ABBV)

TIPRANKS
·
10 Jun

Analysts Are Neutral on These Healthcare Stocks: AbbVie (ABBV), Bio-Techne (TECH)

TIPRANKS
·
10 Jun

Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector?

Dow Jones
·
07 Jun

AbbVie call volume above normal and directionally bullish

TIPRANKS
·
04 Jun

High Growth Tech Stocks To Watch In The US June 2025

Simply Wall St.
·
03 Jun

Kymera Stock Jumps. New Dermatitis Pill Could Challenge Regeneron Blockbuster. -- Barrons.com

Dow Jones
·
02 Jun

BUZZ-Xilio Therapeutics drops on equity raise plans

Reuters
·
02 Jun

Analysts Have Conflicting Sentiments on These Healthcare Companies: AbbVie (ABBV) and Gilead Sciences (GILD)

TIPRANKS
·
02 Jun

Berenberg Adjusts Price Target on AbbVie to $170 From $195, Maintains Hold Rating

MT Newswires Live
·
30 May

U.S. RESEARCH ROUNDUP-Burlington Stores, Tronox Holdings, Zscaler

Reuters
·
30 May

Meet the New Group of Weight-Loss Drugs. The Industry Is Betting Big on Amylin. -- Barrons.com

Dow Jones
·
30 May

AbbVie (NYSE:ABBV) Showcases Promising Phase 1 ADC Results For Advanced Cancers

Simply Wall St.
·
29 May

AbbVie put volume heavy and directionally bearish

TIPRANKS
·
28 May

Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?

Zacks
·
28 May

AbbVie Inc. Stock Rises Tuesday, Still Underperforms Market

Dow Jones
·
28 May

Organon, Samsung Bioepis Say FDA Grants Interchangeability Designation to Hadlima

MT Newswires Live
·
27 May

AbbVie Features New Data Across Difficult-to-Treat Solid Tumors and Blood Cancers at ASCO 2025, Highlighting Breadth and Depth of its Oncology Portfolio

PR Newswire
·
27 May

Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1

StockStory
·
27 May

Health Rounds: Researchers identify best drugs for severe COVID

Reuters
·
23 May